Pharmafile Logo

Lucid Group has four programmes shortlisted for PMEA 2019

Lucid is celebrating four of their programmes being shortlisted in four categories at this year’s PMEAs

- PMLiVE

Lucid’s talent for partnering with its clients to create magical healthcare communications is evident as they celebrate four of their programmes making the PMEA 2019 finals.

Jan Steele, Lucid Group COO and Co-founder commented, “2019 has been a transformative year for Lucid Group. We have gone through two acquisitions, allowing us to increase capability and reach. With all this change, it is a testament to our team’s dedication and passion that they continue to deliver outstanding work for our clients. I do not doubt that as we move into 2020 we will continue this incredible momentum with our work helping to transform more lives than ever before.”

PMEA recognises the achievements of responsible customer-centric business practices that provide patients with meaningful outcomes. The winners will be announced on Wednesday 27 November 2019 at the Royal Lancaster London.

More details about the shortlisted programmes can be found below:

Category: Excellence in Healthcare Professional Education and Support Programmes:   
CLEAR HORIZONS: A new era of psoriasis care
INSPIRE: Improving outcomes in paediatric cardiology

Category: Excellence in Capability Development
Global Medical Affairs as CATALYSTs for change

Category: Excellence in Innovation
DermDialogue: Bringing innovation to MSL‐led education

Excellence in Rare Diseases and Orphan Drugs
INSPIRE: Improving outcomes in paediatric cardiology

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women's Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...